CD1d-restricted help to B cells by human invariant natural killer T lymphocytes

被引:198
作者
Galli, G
Nuti, S
Tavarini, S
Galli-Stampino, L
De Lalla, C
Casorati, G
Dellabona, P
Abrignani, S
机构
[1] IRIS, Res Ctr, Chiron Vaccines, I-53100 Siena, Italy
[2] Ist Sci San Raffaele, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy
关键词
autoreactivity; cytokine; a-galactosylceramide; antibodies; helper assay;
D O I
10.1084/jem.20021616
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant natural killer T (NKT) cells are a highly conserved subset of T lymphocytes expressing a semi-invariant T cell receptor (TCR), which is restricted to CD1d and specific for the glycosphingolipid antigen alpha-galactosylceramide. Their ability to secrete a variety of cytokines, which in turn modulate the activation of cells of both innate and acquired immune responses, suggests that invariant NKT cells exert a regulatory role mainly via indirect mechanisms. A relevant question is whether invariant NKT cells can directly help B cells. We document here that human invariant NKT cells are as efficient as conventional CD4(+) Th0 lymphocytes in promoting proliferation of autologous memory and naive B lymphocytes in vitro, and in inducing immunoglobulin production. Help to B cells by invariant NKT cells is CD1d-dependent and delivered also in the absence of a-galactosylceramide, suggesting that NKT cells recognize an endogenous ligand presented by CD1d on B cells. The two major subsets of invariant NKT cells, CD4(+) and double negative (CD4(-)CD8(-)), express comparable levels of CD40 ligand and cytokines, but differ in helper functions. Indeed, both subsets induce similar levels of B cell proliferation, whereas CD4(+) NKT cells induce higher levels of immunoglobulin production. These results suggest a direct role for invariant NKT cells in regulating B lymphocyte proliferation and effector functions.
引用
收藏
页码:1051 / 1057
页数:7
相关论文
共 30 条
[1]   CD27: a memory B-cell marker [J].
Agematsu, K ;
Hokibara, S ;
Nagumo, H ;
Komiyama, A .
IMMUNOLOGY TODAY, 2000, 21 (05) :204-206
[2]   Mouse CD1-specific NK1 T cells: Development, specificity, and function [J].
Bendelac, A ;
Rivera, MN ;
Park, SH ;
Roark, JH .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :535-562
[3]   CD1d-restricted mouse Vα14 and human Vα24 T cells:: lymphocytes of innate immunity [J].
Benlagha, K ;
Bendelac, A .
SEMINARS IN IMMUNOLOGY, 2000, 12 (06) :537-542
[4]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[5]  
Burdin N, 1999, EUR J IMMUNOL, V29, P2014, DOI 10.1002/(SICI)1521-4141(199906)29:06<2014::AID-IMMU2014>3.0.CO
[6]  
2-G
[7]  
Carnaud C, 1999, J IMMUNOL, V163, P4647
[8]   Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Vα14 natural killer T cells [J].
Cui, JQ ;
Watanabe, N ;
Kawano, T ;
Yamashita, M ;
Kamata, T ;
Shimizu, C ;
Kimura, M ;
Shimizu, E ;
Koike, J ;
Koseki, H ;
Tanaka, Y ;
Taniguchi, M ;
Nakayama, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :783-792
[9]   Chemokines - Chemokines and cell migration in secondary lymphoid organs [J].
Cyster, JG .
SCIENCE, 1999, 286 (5447) :2098-2102
[10]  
D'Andrea A, 2000, EUR J IMMUNOL, V30, P1544, DOI 10.1002/1521-4141(200006)30:6<1544::AID-IMMU1544>3.0.CO